Table 2. Cancer related information of study participants according to primary cancer site.
| Cancer parameters | Total (n = 444) | Stomach (n = 173) | Breast (n = 112) | Lung (n = 42) | Thyroid (n = 37) | Other (n = 80) |
|---|---|---|---|---|---|---|
| Stage of primary cancer, % | ||||||
| I | 52.5 | 53.3 | 43.6 | 62.5 | 61.3 | 52.3 |
| II | 24.9 | 33.3 | 32.7 | 12.5 | 9.7 | 15.9 |
| III & IV | 19.0 | 13.3 | 14.5 | 25.0 | 29.0 | 25.0 |
| Unknown | 3.6 | 0 | 9.1 | 0 | 0 | 6.8 |
| Cancer treatment received, % | ||||||
| Surgery | 96.1 | 93.8 | 100 | 95.1 | 97.1 | 88.0 |
| Chemotherapy | 41.4 | 37.0 | 70.0 | 35.0 | 0 | 30.1 |
| Radiotherapy | 37.4 | 24.1 | 76.4 | 17.5 | 3.0 | 35.7 |
| Hormone therapy | 1.6 | - | 59.6 | - | - | - |
| Metastasis at diagnosis | 1.3 | 0.6 | 0 | 2.6 | 3.4 | 2.2 |
| Recurrence | 1.6 | 1.3 | 3.0 | 2.8 | 0 | 0 |
| Development of second primary cancer* | 3.9 | 1.1 | 8.9 | 2.4 | 0 | 5.0 |
| Family history of cancer | 47.5 | 43.9 | 50.0 | 40.5 | 45.9 | 56.3 |
| Total FCRI score† | 59.2 (24.5) | 57.2 (24.1)‡ | 67.0 (24.3)‡ | 52.9 (22.5)‡ | 56.7 (28.0) | 57.0 (23.2) |
Values are presented as percentage or mean (SD).
FCRI = Fear of Cancer Recurrence Inventory, SD = standard deviation, ANOVA = analysis of variance, FCR = fear of cancer recurrence.
*Cancer sites of second primary cancer (number of cases) were thyroid (n = 10), breast (n = 3), stomach (n = 2), lung (n = 1), and ovary cancer (n = 1). †The difference among cancer site obtained by the ANOVA with post hoc comparison after adjusted for year since diagnosis, sex and canter stage. ‡P < 0.05, breast cancer patients had a higher level of FCR.